WeVote
Log In

Bill

Bill

SF 1752

Coverage of over-the-counter contraceptive, drugs, devices, and products requirement by insurers and medical assistance

2025-2026 Regular Session Introduced by Alice Mann and 4 co-sponsors

Minnesota bill requires health insurers and state Medicaid to cover OTC contraceptives at zero cost-share, removing financial barriers to birth control access.

Authors added Johnson Stewart; Mitchell
#drugsandmedicine #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · SF 1752

Legislative bill overview

SF 1752 requires health insurance plans and state medical assistance programs (like Minnesota Medical Assistance) to cover over-the-counter contraceptive products without cost-sharing, including pills, patches, rings, barrier methods, and emergency contraception. The bill mandates coverage at 100% with no copayments, coinsurance, or deductibles applied to these products.

Why is this important

Removing financial barriers to contraception access affects reproductive healthcare affordability for thousands of Minnesotans. This aligns with federal recommendations from the American College of Obstetricians and Gynecologists and reflects a policy shift toward preventive reproductive health, though it also represents a significant insurance coverage expansion with budgetary implications.

Potential points of contention

  • Cost allocation: Mandated coverage without cost-sharing increases insurance plan expenses, which may be passed to employers, workers, or state budgets depending on plan type and funding structure
  • Scope definition: Determining which OTC products qualify as "contraceptive" (particularly borderline items) and establishing formulary lists could create implementation complexity
  • Insurance market impact: Requirements on private insurers may affect premium pricing and plan offerings, while state medical assistance expansion directly impacts state budget obligations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.